Despite the widespread availability of safe and affordable vaccines, measles continues to be one of the leading causes of death among young children.

Between 2000 and 2016, measles vaccinations resulted in an 84% drop in measles deaths globally, and are thought to have prevented an estimated 20.4 million deaths. Despite the immensely positive impact of the measles vaccine, cases of measles have hit a record high in Europe this year, growing from 5,200 in 2016 to a whopping 41,000 cases in 2018 so far.

The highest rates of outbreaks have been linked to regions in Eastern Europe, but have spread to Italy, France, and the UK. In Italy, legislation that prevented children from attending school unless vaccinated was recently repealed, in a move which is sure to inhibit prevention measures against this highly contagious disease.

Cases of measles are confirmed through infection disease in-vitro diagnostics, a market that has been exhibiting steady global growth. As the anti-vaccination movement spreads, this market, valued at roughly $28bn globally, will likely experience a boost with the influx of patients suffering from once preventable diseases.